Charlotte, NC – January 8, 2008 – Frontier Capital, a private equity firm providing growth equity to business services companies, announced today that it has completed a $10 million investment in Inclinix, Inc., a leading provider of clinical trial recruitment solutions. Frontier’s investment, which includes participation from the Firm’s limited partners, will support expansion of sales and marketing resources and enhancement of the company’s proprietary clinical trial enrollment processes and technologies.

Based in Wilmington, NC, Inclinix provides clinical trial patient recruitment solutions to pharmaceutical, biotechnology, and medical-device companies. Customers rely on Inclinix’s full lifecycle recruitment solution to identify, qualify and deliver participants for enrollment in clinical drug trials. Inclinix’s proven technology-enabled solutions have enabled the Company to establish a leadership position in an industry that increasingly depends on patient recruitment expertise to meet enrollment goals for clinical trials.

“Over the past three years, we have consistently experienced exceptional growth. This growth can be attributed to the value of our solution as we have become a trusted partner for some of the largest and most influential drug development companies in the world,” said Tobin Geatz, chief executive officer of Inclinix. “With this funding from Frontier Capital, we will be able to accelerate the development of our innovative technology, build out our operations, and increase the industry leading service levels that have come to define the standards for patient recruitment.”

“We have been very impressed with the significant progress and evolution of Inclinix over the last three years,” said Michael Ramich, partner of Frontier Capital. “Through the Company’s innovative approach to patient recruitment and its technology-enabled delivery platform, Inclinix has become an invaluable partner to companies facing increasing difficulty in recruiting patients for trials. We are pleased to partner with Inclinix in accelerating the Company’s growth trajectory.”

Frontier Capital invests in business services companies with a differentiated solution in the marketplace and a need for capital to accelerate growth, make acquisitions, or generate shareholder liquidity. All investments are based on strong partnerships with management. The firm and its Operating Partners provide valuable resources beyond capital. Frontier’s investments are similar in nature and stage, resulting in the opportunity to share best practices and experiences across its portfolio.

About Inclinix
Founded in 1999, Inclinix, Inc. is the industry’s Enrollment CRO. Inclinix’s
IQM? Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit www.inclinix.com.

About Frontier Capital
Frontier Capital is a private equity firm providing growth equity to business service companies. These companies range from traditional to tech-enabled and deliver a differentiated service to their customers. They have a proven solution in the marketplace and need capital to accelerate growth, make acquisitions, or generate shareholder liquidity. The firm is based in Charlotte, N.C. and provides $5-$10 million per investment in companies throughout the Southeast and Mid-Atlantic regions. For more information on Frontier Capital, visit www.frontiercapital.com.

Press Contact Information

Frontier Capital
jpurdy@itconscious.com
704-236-2501
1900 South Boulevard, Suite 300 Charlotte, NC 28203

Source URL: http://www.frontiercapital.com

Who Read this Press Release